Evidence map›Paper›PMID 36903781›Full record

ReviewNanomaterials (Basel, Switzerland)2023

In Vitro Models of Bacterial Biofilms: Innovative Tools to Improve Understanding and Treatment of Infections.

G Crivello, L Fracchia, G Ciardelli, M Boffito, C Mattu

Full text readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Bacteriophage-Based Control of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Towards improved biofilm models.Nature reviews. Microbiology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

G CrivelloDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, C.so Duca degli Abruzzi 24, 10129 Torino, Italy.ORCID 0000-0002-4095-4568
L FracchiaDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", Largo Donegani 2, 28100 Novara, Italy.ORCID 0000-0003-3505-1919
G CiardelliDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, C.so Duca degli Abruzzi 24, 10129 Torino, Italy.ORCID 0000-0003-0199-1427
M BoffitoDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, C.so Duca degli Abruzzi 24, 10129 Torino, Italy.ORCID 0000-0001-7637-2001
C MattuDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, C.so Duca degli Abruzzi 24, 10129 Torino, Italy.ORCID 0000-0002-3969-8771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial infections are a growing concern to the health care systems. Bacteria in the human body are often found embedded in a dense 3D structure, the biofilm, which makes their eradication even more challenging. Indeed, bacteria in biofilm are protected from external hazards and are more prone to develop antibiotic resistance. Moreover, biofilms are highly heterogeneous, with properties dependent on the bacteria species, the anatomic localization, and the nutrient/flow conditions. Therefore, antibiotic screening and testing would strongly benefit from reliable

Indexed as

3D printingbacteriabiofilm modelsinfectionin vitro modelsmicrocosm modelsmicrofluidics

Identifiers

PMID36903781
PMCPMC10004855

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read20
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.